In recent years, there has been considerable interest in ferritin as a
n oncofetal protein. However, the clinical significance of ferritin ex
pression in cancer tissues remains unknown. We performed an immunohist
ochemical study to examine the expression of ferritin in colorectal ad
enocarcinoma (n=104). A total of 95 out of 104 (91.3%) colon cancers w
ere positive for ferritin expression. The degree of immunoreactivity h
as no significant correlation with tumor grade (p=0.964), size (p=0.65
9), serosal invasion (p=0.331), nodal metastasis (p=0.955), distant me
tastasis (p=0.354) and DNA ploidy status (p=0.126), but there was a st
rong association between ferritin expression of tumor cells and stroma
l mononuclear cell infiltration (p=0.004). In terms of prognostic sign
ificance, multivariate analysis showed that nodal metastasis (p=0.0123
) and distant metastasis (p=0.0237) were independent poor prognostic f
actors. However, there was no significant difference in survival betwe
en patients with weak and strong ferritin expression in cancer tissues
(p=0.3766). The results indicate that the majority of colorectal aden
ocarcinomas exhibit ferritin expression. The grade of ferritin express
ion is strongly associated with stromal mononuclear cell infiltration,
but has no significant correlation with any staging parameters or the
survival of cancer patients.